Dr. Mark Socinski is the Executive Medical Director of the AdventHealth Cancer Institute in Orlando, FL. Dr. Socinski received his medical degree from the University of Vermont, College of Medicine. His postdoctoral training included an internship and residency in internal medicine at the Beth Israel Hospital, Harvard Medical School and a medical oncology fellowship at the Dana-Farber Cancer Institute, Harvard Medical School. Dr. Socinski was most recently the Director of the Lung Cancer Section at the University of Pittsburgh Medical Center, Clinical Associate Director of the University of Pittsburgh Lung Cancer SPORE, Co-Director of UPMC Lung Cancer Center of Excellence, and Co-Leader of the Lung Cancer Program at the University of Pittsburgh Cancer Institute.

Dr. Socinski holds membership in numerous professional societies such as the American College of Physicians, American Society of Clinical Oncology, Cancer and Leukemia Group B (Alliance), International Association for the Study of Lung Cancer, American College of Chest Physicians. Dr. Socinski is also co-Chair Emeritus of the Thoracic Malignancies Steering Committee for the National Cancer Institute.

Dr. Socinski is well-published in peer-reviewed literature in outstanding journals as the Journal of Clinical Oncology, Journal of Thoracic Oncology, Cancer, and Lancet Oncology. Dr. Socinski’s primary research interests reside in all aspects of clinical trials related to the thoracic oncology population. He also has been instrumental in the development of many cooperative group and investigator-initiated clinical trials.